Rudolph E. Tanzi, PhD, Harvard University

Neurology Harvard Medical School, Boston, MA, United States 
"Rudolph Tanzi"

Cross-listing: Neurotree


Sign in to add trainee
Doo Yeon Kim grad student (Neurotree)
Julien Muffat grad student Harvard Medical School (Neurotree)
Mehdi Jorfi post-doc (Neurotree)
Dora Kovacs post-doc Harvard Medical School
Joseph Park post-doc (Neurotree)
Wilma Wasco post-doc MGH/Harvard Medical
Ashley I. Bush post-doc 1992-1994 Harvard Medical School
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wittrahm R, Takalo M, Kuulasmaa T, et al. (2023) Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models. Neurobiology of Disease. 106140
Chen XQ, Sawa M, Becker A, et al. (2023) Retromer proteins reduced in Down syndrome and the Dp16 model: impact of APP dose and preclinical studies of a γ-secretase modulator. Annals of Neurology
Choi SH, Tanzi RE. (2023) Adult neurogenesis in Alzheimer's disease. Hippocampus
Salta E, Lazarov O, Fitzsimons CP, et al. (2023) Adult hippocampal neurogenesis in Alzheimer's disease: A roadmap to clinical relevance. Cell Stem Cell. 30: 120-136
Jorfi M, Maaser-Hecker A, Tanzi RE. (2023) The neuroimmune axis of Alzheimer's disease. Genome Medicine. 15: 6
Hebisch M, Klostermeier S, Wolf K, et al. (2023) The Impact of the Cellular Environment and Aging on Modeling Alzheimer's Disease in 3D Cell Culture Models. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2205037
Bai P, Mondal P, Bagdasarian FA, et al. (2022) Development of a potential PET probe for HDAC6 imaging in Alzheimer's disease. Acta Pharmaceutica Sinica. B. 12: 3891-3904
Whitson HE, Colton C, El Khoury J, et al. (2022) Infection and inflammation: New perspectives on Alzheimer's disease. Brain, Behavior, & Immunity - Health. 22: 100462
Morgan SL, Naderi P, Koler K, et al. (2022) Most Pathways Can Be Related to the Pathogenesis of Alzheimer's Disease. Frontiers in Aging Neuroscience. 14: 846902
Liang Y, Lee DYW, Zhen S, et al. (2022) Natural medicine HLXL targets multiple pathways of amyloid-mediated neuroinflammation and immune response in treating alzheimer's disease. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 104: 154158
See more...